John-Arne Røttingen

John-Arne Røttingen (born 27 March 1969) is a Norwegian medical scientist, research administrator and civil servant. He is the current Chief executive officer of the Research Council of Norway, and has been a special advisor to the World Health Organization (WHO).

John-Arne Røttingen
Røttingen in 2015
Born (1969-03-27) 27 March 1969
Alma materUniversity of Oslo
Occupationmedical scientist, research administrator and civil servant
Employer

Early life

Røttingen is from Bø, Telemark. He graduated as cand.med. in 1996 and dr.med. in 1999 from the University of Oslo, and then from the University of Oxford, and Harvard Kennedy School.[1] He was a researcher at the University of Oslo and at the Harvard School of Public Health. His research interests have been epidemiology and global health.[2]

Career

Earlier in his career, Røttingen worked as executive director of infection control and environmental health at the Norwegian Institute of Public Health (NIPH).[3] In this capacity, he also chaired the WHO's Consultative Expert Working Group on Research and Development from 2010 until 2012.[4]

In January 2017, Røttingen served as interim CEO for the launch of Coalition for Epidemic Preparedness Innovations at the World Economic Forum in Davos.[5][6] Since its inception in 2017, he has been also a member the Scientific Advisory Group of the WHO R&D Blueprint, a global strategy and preparedness plan that allows the rapid activation of research activities during epidemics, chaired by Jeremy Farrar.[7]

In March 2017, Røttingen was appointed CEO of the Research Council of Norway.[8][9]

In early 2021, Røttingen was appointed by the G20 to the High Level Independent Panel (HLIP) on financing the global commons for pandemic preparedness and response, co-chaired by Ngozi Okonjo-Iweala, Tharman Shanmugaratnam and Lawrence Summers.[10]

See also

References

Academic offices
Preceded by
Arvid Hallén
Director of the Research Council of Norway
2017
Succeeded by
Incumbent
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.